Clinical Trial Update: Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial update on weekly paclitaxel/carboplatin with Neupogen in gynecologic cancers (ovarian, endometrial, and cervical) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Neupogen (Filgrastim)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Belgian Gynaecological Oncology Group | Conditions: Ovarian Cancer, Endometrial Cancer | Phase 2 | Status: COMPLETED